Skip to content
Vium logo — Creating digital biomarkers to transform preclinical researc...

Vium

Creating digital biomarkers to transform preclinical research and animal welfare.

Founded 2013 United States San Mateo, United States 5 employees Series B Total: $53.94M Biotechnology, Health Care +2

General Information

Company Name Vium
Founded Year 2013
Location United States San Mateo, United States
Founders / Decision Makers
Team member
Employees 5
Industries Biotechnology, Health Care, Life Sciences +1
Funding Stage Series B
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Usage Based, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with Vium. To contact Vium, visit vium.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Vium compare?

A PDF of Vium and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Vium soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Vium

Vium, founded in 2013 and headquartered in the United States, is pioneering a transformation in preclinical research with its slogan, "Creating digital biomarkers to transform preclinical research and animal welfare." The company stands at the forefront of innovation with the Vium Digital Vivarium™, a platform that integrates Vium Smart Housing™, a robust cloud infrastructure, and their intuitive online Research Suite. This offering optimizes the utilization of bioengineered research models in unprecedented ways.

Vium is positioned at the intersection of Biotechnology, Health Care, Life Sciences, and Medical Devices, serving a broad clientele ranging from biotechnology firms to academic labs. Notably, the company has earned accreditation by AAALAC International with a commendation for its adherence to humane research practices.

The firm secured a $24.00M Series B investment on June 21, 2018 from prominent backers including Founders Fund, Lux Capital, DCVC, Dolby Ventures, and Future Shape, underscoring robust investor confidence in its potential to revolutionize drug research.

Business keywords: preclinical research, digital biomarkers, animal welfare, AAALAC accreditation, drug research, Vium Digital Vivarium, Vium Smart Housing, Vium Cloud infrastructure, Research Suite software, bioengineered research models, investment, physiological biomarkers

Services & Products

Domain Marketplace Exploration
Domain Acquisition and Transfer
AI and Human Naming Solutions
Trademark Filing and Protection
Instant Logo Creation
Domain Appraisal Services

Target Customers

Business Owners Entrepreneurs Brand Managers Marketing Agencies Startups

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $24.00M 5
Founders Fund, Lux Capital +3
21 Jun 2018
Series A $20.00M 5
Founders Fund, Lux Capital +3
09 Jun 2015
Series A $8.80M -
29 Oct 2014
Seed Round $1.14M -
01 Mar 2014

Vium Alternatives & Competitors

View All Alternatives
Vium vs
RockStep Solutions
RockStep Solutions United States

Modernize in vivo research

Debt Financing
33 employees
Analytics, Health Care
Vium vs

Turning hits into IND-ready therapies — integrated preclinical science that speeds your path to clin...

23 employees
Biotechnology, Life Sciences
Vium vs

Preclinical CRO-in vitro and in vivo testing services for cell and gene therapy, biologics, vaccines...

Seed
38 employees
Biotechnology, Life Sciences

FAQ About Vium

Creating digital biomarkers to transform preclinical research and animal welfare.
Vium was founded in 2013.
Vium is headquartered in San Mateo, United States.
Vium operates in Biotechnology, Health Care, Life Sciences and Medical Devices. Its work centres on preclinical research, digital biomarkers, animal welfare and AAALAC accreditation. Its customers include Business Owners, Entrepreneurs and Brand Managers.
Vium has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Usage Based and Tiered Pricing.
Vium has approximately 5 employees.
Vium has completed 4 funding rounds, raising a total of $53.94M. The latest funding stage is Series B.
Vium offers: Domain Marketplace Exploration, Domain Acquisition and Transfer, AI and Human Naming Solutions, Trademark Filing and Protection, Instant Logo Creation, Domain Appraisal Services.
Top alternatives and competitors to Vium include RockStep Solutions, TheraIndx Lifesciences Pvt.Ltd., Noble Life Sciences Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vium and RockStep Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Vium, https://www.bouncewatch.com/company/vium, updated 19 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout